← Open Payments lookup

PAMELA CHADWELL: Open Payments

NPI 1861434623 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$430 in 15 payments from 10 companies in 2025. Trend: 2023 $316 · 2024 $1,125 · 2025 $430

Food & beverage: $430
CompanyPaymentsAmount
ACADIA Pharmaceuticals Inc1$110
Neurocrine BioSciences, Inc.2$84
Viatris Specialty LLC3$69
Otsuka America Pharmaceutical, Inc.2$41
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$35
PFIZER INC.1$20
Aimmune Therapeutics, Inc.1$20
Teva Pharmaceuticals USA, Inc.1$18
JAZZ PHARMACEUTICALS INC.1$18
Otsuka Pharmaceutical Development & Commercialization, Inc.1$16

Products named: NUPLAZID, INGREZZA, YUPELRI, REXULTI, XIFAXAN, NURTEC ODT, ZENPEP, AUSTEDO XR.

Industry payments across OK — which companies pay providers there.